Market Tracker

10/24 6:05pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.00
Data as of Oct 24
 +0.17 / +2.17%
Today’s Change
6.28
Today|||52-Week Range
31.73
-48.15%
Year-to-Date

Today’s Trading

Previous close7.83
Today’s open7.81
Day’s range7.81 - 8.19
Volume21,148
Average volume (3 months)48,235
Market cap$79.6M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.81

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc-0.16-3.88%
CNDOCoronado Biosciences...0.000.00%
HSKAHeska Corp+0.31+2.48%
IMMYImprimis Pharmaceuti...+0.61+7.39%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts